Header Logo

Connection

LOIS M RAMONDETTA to Neoplasms, Hormone-Dependent

Back to Details
This is a "connection" page, showing publications LOIS M RAMONDETTA has written about Neoplasms, Hormone-Dependent.
LOIS M RAMONDETTA
Connection Strength
0.073
Neoplasms, Hormone-Dependent
  1. Phase 2 trial of mifepristone (RU-486) in advanced or recurrent endometrioid adenocarcinoma or low-grade endometrial stromal sarcoma. Cancer. 2009 May 01; 115(9):1867-74.
    View in: PubMed
    Score: 0.073
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.